Product Description
Mechanisms of Action: N/A
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
05/14/2024 |
PubMed |
Comparative metabolite analysis of Piper sarmentosum organs approached by LC-MS-based metabolic profiling. |
|
03/19/2024 |
PubMed |
Association between amino acids and recent osteoporotic fracture: a matched incident case-control study. |
|
12/12/2023 |
PubMed |
Piperine: Chemistry and Biology. |